Cancer immunology is advancing rapidly as researchers seek to unravel the complex, dynamic relationships between tumor cells, immune populations, and the ...

The idea that cells could be reset emerged from decades of research in regenerative medicine. The field traces back to 1962, ...

Dr. Georg Winter explores how chemical neomorphs can give proteins new functions by reshaping their cellular interactions, ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced data from an investigator-initiated Phase II trial at Memorial Sloan Kettering Cancer Center, investigating ...

First study of agenT-797, botensilimab (BOT) and balstilimab (BAL) in gastroesophageal cancer shows disease control rate (DCR) in 77% of patients ...

Discover the top founders and coaches to watch in 2026—visionary leaders shaping business, mindset, and innovation. From ...

Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...

Creative Biogene is proud to announce the launch of its innovative iPSC RNA reprogramming products, specifically designed to enhance the efficiency and safety of iPSC generation.

A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...

May 1, 2026, marks the 45th birthday of the Communications-Electronics Command. Throughout its history, responsibilities and ...

BIO Capital continues support as founding investor, having backed Ray Therapeutics since seed funding in 2021 through Series ...

The Navy wants to buy the first Trump-class battleship in next year’s budget submission, a schedule that would allow the ...